|
Post by smwill77 on Feb 10, 2016 20:39:19 GMT -5
Here here!!
|
|
|
Post by jurystillout on Feb 10, 2016 20:44:51 GMT -5
In an e-mail to ir@mannkindcorp.com prior to the CC, I specifically asked the question regarding how operations will be funded in short term,intermediate and long term while product revenue is being built. I plan to write another polite e-mail to the same address asking the same question, Please do the same, it would be very interesting to see how many of us ask this most important question and if it is addressed.
|
|
|
Post by dreamboatcruise on Feb 10, 2016 20:52:51 GMT -5
In an e-mail to ir@mannkindcorp.com prior to the CC, I specifically asked the question regarding how operations will be funded in short term,intermediate and long term while product revenue is being built. I plan to write another polite e-mail to the same address asking the same question, Please do the same, it would be very interesting to see how many of us ask this most important question and if it is addressed. They simply can't say at this point. They have mentioned things they will pursue, but they can't promise or imply that any or all will come to fruition. It's a horrible position to be in as an investor, but until one of these material cash events happen we are unlikely to get any sort of meaningful indication of probability or timing.
|
|
|
Post by jurystillout on Feb 11, 2016 13:41:31 GMT -5
In an e-mail to ir@mannkindcorp.com prior to the CC, I specifically asked the question regarding how operations will be funded in short term,intermediate and long term while product revenue is being built. I plan to write another polite e-mail to the same address asking the same question, Please do the same, it would be very interesting to see how many of us ask this most important question and if it is addressed. They simply can't say at this point. They have mentioned things they will pursue, but they can't promise or imply that any or all will come to fruition. It's a horrible position to be in as an investor, but until one of these material cash events happen we are unlikely to get any sort of meaningful indication of probability or timing. If your right and they can't say because they don't know, that in itself is very important to know and get confirmation of that from Matt. If you're running a business and you really don't know how your going to pay your bills you are in very significant trouble. If you have "potential" income you also need "Plan B" (liquidation, layoffs, suspending operations, borrow from Mom&Dad....) This is the plan that I would like to see and I believe Matt is a savvy enough bean counter to have a plan in place.
|
|
|
Post by dreamboatcruise on Feb 11, 2016 13:57:59 GMT -5
They simply can't say at this point. They have mentioned things they will pursue, but they can't promise or imply that any or all will come to fruition. It's a horrible position to be in as an investor, but until one of these material cash events happen we are unlikely to get any sort of meaningful indication of probability or timing. If your right and they can't say because they don't know, that in itself is very important to know and get confirmation of that from Matt. If you're running a business and you really don't know how your going to pay your bills you are in very significant trouble. If you have "potential" income you also need "Plan B" (liquidation, layoffs, suspending operations, borrow from Mom&Dad....) This is the plan that I would like to see and I believe Matt is a savvy enough bean counter to have a plan in place. I would assume it isn't exactly a Plan A vs B thing, but rather a list of possible actions involving either raising cash or cutting expense and they likely have them roughly ranked based on desirability... with many dependent on negotiations with outside entities and thus at best with only a rough probability attached to them The effort put into these would presumably be based on some combination of desirability and potential time frame for each. As we learned with TASE, MNKD is unlikely to tip their hat early about deals before they are finalized (as is normal for any public company), and even then plans don't always go according to script. I'm sure Matt is on top of things, but MNKD is really between a rock and a hard place given the fact that raising any significant capital in the markets would seem highly improbable at the present time both because of MNKD specifics and markets in general.
|
|
|
Post by steve on Feb 11, 2016 18:34:20 GMT -5
Many thanks for posting as I may have missed this.
|
|
|
Post by tayl5 on Feb 11, 2016 21:15:48 GMT -5
Interesting part on the AMPH supply. Was not aware they had neg'd this already. (I don't know if this is new info or not?). Need to look back at the 10q's to get a better handle on it, but savings in this area will certainly help. That came as new info to me as well. I'm also delighted to hear that the AMPH purchase commitment was renegotiated. Forcing product on a customer when the customer's circumstances have changed and they can't use the product is never a good idea. I applaud AMPH for recognizing that and making the right decision.
|
|
|
Post by sluggobear on Feb 11, 2016 21:46:25 GMT -5
If your right and they can't say because they don't know, that in itself is very important to know and get confirmation of that from Matt. If you're running a business and you really don't know how your going to pay your bills you are in very significant trouble. If you have "potential" income you also need "Plan B" (liquidation, layoffs, suspending operations, borrow from Mom&Dad....) This is the plan that I would like to see and I believe Matt is a savvy enough bean counter to have a plan in place. I would assume it isn't exactly a Plan A vs B thing, but rather a list of possible actions involving either raising cash or cutting expense and they likely have them roughly ranked based on desirability... with many dependent on negotiations with outside entities and thus at best with only a rough probability attached to them The effort put into these would presumably be based on some combination of desirability and potential time frame for each. As we learned with TASE, MNKD is unlikely to tip their hat early about deals before they are finalized (as is normal for any public company), and even then plans don't always go according to script. I'm sure Matt is on top of things, but MNKD is really between a rock and a hard place given the fact that raising any significant capital in the markets would seem highly improbable at the present time both because of MNKD specifics and markets in general. Regarding the FAQ's - I thought they were really good. But I have to wonder if my expectations are very low. I hope the Receptor deal becomes more transparent and we can judge soon what the time frame will be for potential milestones. But even if they got all $105m at once that is 6 months to a year at best with current spend levels. So this makes me speculate (ugh) - if they know they were going to run out of cash and had nothing fairly substantial expected for a new source of funds this year, wouldn't they / shouldn't they be really cutting back to the bare bone? I guess if they announce big cuts in R&D we will have our answer... This is the second company I have watched from the sidelines get close to running out of cash and/or heard the term "death spiral" come up. The other one is Lexicon which I'm happy to say has really done the right things to come back from the brink. But after making good changes, they got new infusions of cash through a large dilution. I bought right before the dilution...so savvy. BTW - they had no problem selling their stock. And they also were bouncing around at about .90 before doing a 1:7 RS. Has anyone here witnessed public companies in similar situations to MNKD? Can you comment on their lackadaisical attitude? If there isn't something big around the corner then what would they be thinking? I guess all options are always on the table but if they had nothing concrete, wouldn't they be making huge cuts now? Or is it too late for that? If interested, here is a summary of what Lexicon did to get their cash back up: seekingalpha.com/article/2704175-a-change-in-strategy-lexicon-pharmaceuticals
|
|
|
Post by sportsrancho on Feb 12, 2016 15:56:03 GMT -5
The question about Al is interesting, because although the "can Al?" portion of the question was left unanswered, we have evidence that he is still actively involved and still enthusiastic about Afrezza. Just a couple of weeks ago, based on the transcript of the interview the the Dexcom CEO, we know that Al is still traveling (Boston), meeting with executives (Dexcom CEO) and still very interested in talking about Afrezza (Dexcom CEO said he spent a long time talking about Afrezza with Al). Still, I'd really like to hear him address shareholders directly. He is so much more inspirational than Matt or Hakan. Re-posting for those who missed this.
|
|
|
Post by compound26 on Feb 12, 2016 16:19:11 GMT -5
The question about Al is interesting, because although the "can Al?" portion of the question was left unanswered, we have evidence that he is still actively involved and still enthusiastic about Afrezza. Just a couple of weeks ago, based on the transcript of the interview the the Dexcom CEO, we know that Al is still traveling (Boston), meeting with executives (Dexcom CEO) and still very interested in talking about Afrezza (Dexcom CEO said he spent a long time talking about Afrezza with Al). Still, I'd really like to hear him address shareholders directly. He is so much more inspirational than Matt or Hakan. Re-posting for those who missed this. I searched for this interview, it appears the interview was done in June 2015, although someone re-posted the interview in Yahoo a few days ago: fwww.boardcentral.com/boards/MNKD/138492755_Keep_this_mindredhaw_2000 • Feb 4, 2016 9:01 AM "Google/Sanofi/Dexcom/Joslin Center partnership that was already announced" From last June:
"Kevin Sayer, DexCom, Inc: You know what? We are not working with it, but I do have to tell you I was with Al on Saturday in Boston, and he--I spent a lot of time with him. The Afrezza patient Unidentified Audience Member [26] I'm sorry, what was the question? Kevin Sayer, DexCom, Inc. - CEO [27] He asked if we're working with the inhaled insulin, with MannKind insulin. Many of the Afrezza patients are CGM users and they're Twitter fanatics. They take pictures of their CGM lines because they're flat, because Afrezza works so quickly that they no longer eat a meal and have this big spike in glucose that goes on for a while before the insulin finally kicks in and then takes them way down because the tail lasts so long. They're in heaven. Now I don't know what that means for Afrezza sales, but there is a group of people who absolutely love it and use our product and have very good results. " This is my 5th time trying to post this. Search "Edited Transcript of DXCM presentation 9-Jun-15 9:10pm GMT" for entire presentation
|
|